Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up ☆

ESMO Guidelines Committee

doi:10.1016/j.annonc.2022.10.506

Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up ^☆

ESMO Guidelines Committee

Résultats de recherche: Contribution à un journal › Article › Revue par des pairs

225 Citations (Scopus)

langue originale	Anglais
Pages (de - à)	127-140
Nombre de pages	14
journal	Annals of Oncology
Volume	34
Numéro de publication	2
Les DOIs	https://doi.org/10.1016/j.annonc.2022.10.506
état	Publié - 1 févr. 2023

Accès au document

10.1016/j.annonc.2022.10.506

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{451ae4aa395c4d2284680ba9459c3cd1,

title = "Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up ☆",

keywords = "cholangiocarcinoma, diagnosis, follow-up, gallbladder cancer, precision medicine, treatment",

author = "{ESMO Guidelines Committee} and A. Vogel and J. Bridgewater and J. Edeline and Kelley, {R. K.} and Kl{\"u}mpen, {H. J.} and D. Malka and Primrose, {J. N.} and L. Rimassa and A. Stenzinger and Valle, {J. W.} and M. Ducreux",

note = "Funding Information: AV and MD acknowledge the European Reference Network for Rare Solid Adult Cancers (EURACAN) for valuable input and networking. Manuscript editing support was provided by Richard Lutz and Claire Bramley ( ESMO Guidelines staff) and Angela Corstorphine and Sian-Marie Lucas of Kstorfin Medical Communications Ltd (KMC); this support was funded by ESMO . Nathan Cherny, Chair of the ESMO-MCBS Working Group, Urani Dafni, ESMO-MCBS Working Group Member/Frontier Science Foundation Hellas and Giota Zygoura of Frontier Science Foundation Hellas provided review and validation of the ESMO-MCBS scores. Nicola Latino ( ESMO Scientific Affairs staff) provided coordination and support of the ESMO-MCBS scores and Angela Corstorphine and Sian-Marie Lucas of KMC provided medical writing and editing support in the preparation of the ESMO-MCBS table; this support was funded by ESMO . Dr Benedikt Westphalen (member of the ESMO Translational Research and Precision Medicine Working Group) and Dr Svetlana Jezdic ( ESMO Medical Affairs Advisor) provided validation support for ESCAT scores. ",

year = "2023",

month = feb,

day = "1",

doi = "10.1016/j.annonc.2022.10.506",

language = "English",

volume = "34",

pages = "127--140",

journal = "Annals of Oncology",

issn = "0923-7534",

number = "2",

}

TY - JOUR

T1 - Biliary tract cancer

T2 - ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up ☆

AU - ESMO Guidelines Committee

AU - Vogel, A.

AU - Bridgewater, J.

AU - Edeline, J.

AU - Kelley, R. K.

AU - Klümpen, H. J.

AU - Malka, D.

AU - Primrose, J. N.

AU - Rimassa, L.

AU - Stenzinger, A.

AU - Valle, J. W.

AU - Ducreux, M.

N1 - Funding Information: AV and MD acknowledge the European Reference Network for Rare Solid Adult Cancers (EURACAN) for valuable input and networking. Manuscript editing support was provided by Richard Lutz and Claire Bramley ( ESMO Guidelines staff) and Angela Corstorphine and Sian-Marie Lucas of Kstorfin Medical Communications Ltd (KMC); this support was funded by ESMO . Nathan Cherny, Chair of the ESMO-MCBS Working Group, Urani Dafni, ESMO-MCBS Working Group Member/Frontier Science Foundation Hellas and Giota Zygoura of Frontier Science Foundation Hellas provided review and validation of the ESMO-MCBS scores. Nicola Latino ( ESMO Scientific Affairs staff) provided coordination and support of the ESMO-MCBS scores and Angela Corstorphine and Sian-Marie Lucas of KMC provided medical writing and editing support in the preparation of the ESMO-MCBS table; this support was funded by ESMO . Dr Benedikt Westphalen (member of the ESMO Translational Research and Precision Medicine Working Group) and Dr Svetlana Jezdic ( ESMO Medical Affairs Advisor) provided validation support for ESCAT scores.

PY - 2023/2/1

Y1 - 2023/2/1

KW - cholangiocarcinoma

KW - diagnosis

KW - follow-up

KW - gallbladder cancer

KW - precision medicine

KW - treatment

UR - http://www.scopus.com/inward/record.url?scp=85144478262&partnerID=8YFLogxK

U2 - 10.1016/j.annonc.2022.10.506

DO - 10.1016/j.annonc.2022.10.506

M3 - Article

C2 - 36372281

AN - SCOPUS:85144478262

SN - 0923-7534

VL - 34

SP - 127

EP - 140

JO - Annals of Oncology

JF - Annals of Oncology

IS - 2

ER -